To improve mRNA product analysis, the Lonza Group Ltd. and Oxford Nanopore Technologies plc. are working together to develop and market a test to assess multiple critical quality attributes of […]
Author Archive for: MM
You are here: Home1 / MM
This author has not written his bio yet.
But we are proud to say that MM contributed 2 entries already.
Entries by MM
French Sanofi SA’s second Phase III trial of duplimab demonstrated a 34% reduction in exacerbations and significant lung function improvements.